Taiwan FDA registration 954e780df4f954ab41851158fbc5f79a
Daisling Ryasan CMV immunoglobulin M detection reagent and quality control group
TW: 戴思林禮亞尚巨細胞病毒免疫球蛋白M檢測試劑及品管組
Taiwan·Risk Class 2·DIASORIN S.P.A.·Registered Dec 07, 2006 – Dec 07, 2016CancelledRegistration details
- Analysis ID
- 954e780df4f954ab41851158fbc5f79a
- Customs Code
- DHA00601782408
Company information
- Manufacturer
- DIASORIN S.P.A.
- Manufacturer Country
- Italy
- Authorized Representative
- EVERLIGHT BIOTECH(TAIWAN) CO., LTD.
Product details
- Intended Use
- Chemical cold light immunoassay (CLIA) technology is used to quantitatively determine hCMV-specific immunoglobulin M antibodies in human serum or plasma samples.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.3175 巨細胞病毒血清試劑
- Import Information
- import
Dates and status
- Registration Date
- Dec 07, 2006
- Expiry Date
- Dec 07, 2016
- Cancellation Date
- May 28, 2018
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Daisling Ryasan CMV immunoglobulin M detection reagent and quality control group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 954e780df4f954ab41851158fbc5f79a and manufactured by DIASORIN S.P.A.. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices